NTRR Preps New Test for Booming Cannabis Quality Control Market
As testing continues on Neutra Corp.’s (OTCBB: NTRR) innovative new disposable contaminants test for medical marijuana (MMJ), the marketplace for cannabis testing in the U.S. continues to grow. Twenty states and Washington, D.C., now allow MMJ prescriptions, with Connecticut and Washington state requiring testing for adulterants.
More states are following suit, leading to a boom in the nascent cannabis testing industry, says NTRR CEO Sydney Jim.
“With few rules in place, all sorts of things not visible to the naked eye have been found in MMJ, from mold and mildew to insect parts, salmonella and pesticides,” Mr. Jim said. “Soon, our revolutionary testing product will make contamination analysis faster and easier than it’s ever been before.”
The health effects of MMJ tainted with mold, mildew and other contaminants isn’t yet fully clear, but a study published earlier this year by the Journal of Toxicology found that pesticide residues on cannabis are transferred to inhaled marijuana smoke, potentially posing a “significant toxicological threat.”
To combat the threat, NTRR is designing a disposable testing system to give patients and retailers in the rapidly growing MMJ industry a closer, more detailed look at the plants they’re buying, selling and consuming. If successful, the innovative system could help NTRR capture a big share of a testing market poised for unprecedented growth as more and more states sign MMJ laws.
By providing cutting-edge nutraceutical products and services, Neutra Corp. plans to compete for customers with other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
As testing continues on Neutra Corp.’s (OTCBB: NTRR) innovative new disposable contaminants test for medical marijuana (MMJ), the marketplace for cannabis testing in the U.S. continues to grow. Twenty states and Washington, D.C., now allow MMJ prescriptions, with Connecticut and Washington state requiring testing for adulterants.
More states are following suit, leading to a boom in the nascent cannabis testing industry, says NTRR CEO Sydney Jim.
“With few rules in place, all sorts of things not visible to the naked eye have been found in MMJ, from mold and mildew to insect parts, salmonella and pesticides,” Mr. Jim said. “Soon, our revolutionary testing product will make contamination analysis faster and easier than it’s ever been before.”
The health effects of MMJ tainted with mold, mildew and other contaminants isn’t yet fully clear, but a study published earlier this year by the Journal of Toxicology found that pesticide residues on cannabis are transferred to inhaled marijuana smoke, potentially posing a “significant toxicological threat.”
To combat the threat, NTRR is designing a disposable testing system to give patients and retailers in the rapidly growing MMJ industry a closer, more detailed look at the plants they’re buying, selling and consuming. If successful, the innovative system could help NTRR capture a big share of a testing market poised for unprecedented growth as more and more states sign MMJ laws.
By providing cutting-edge nutraceutical products and services, Neutra Corp. plans to compete for customers with other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.
For more information on NTRR’s initiatives, please visit www.neutracorp.com.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
